# OnCo record susana-banerjee (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/susana-banerjee/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "susana-banerjee" ;
  schema:name "Susana Banerjee"@en ;
  schema:description "London gynaecological oncologist who led RAMP 201, the trial that established the avutometinib and defactinib combination for recurrent KRAS-mutant low-grade serous ovarian cancer."@en ;
  schema:url <https://onco.cc/people/susana-banerjee/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Susana_Banerjee>, <https://orcid.org/0000-0002-8840-7934> ;
  onco:tag "ovarian", "gynaecological", "targeted-therapy", "trialist" ;
  schema:jobTitle "Consultant medical oncologist, The Royal Marsden and The Institute of Cancer Research" ;
  onco:cancers <https://onco.cc/cancers/low-grade-serous-ovarian-cancer/>, <https://onco.cc/cancers/ovarian/> ;
  onco:institutions <https://onco.cc/institutions/royal-marsden/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ramp-201-avutometinib-defactinib-lgsoc-jco-2025/> ;
  schema:affiliation <https://onco.cc/institutions/royal-marsden/> .